Rapid ESBL-Carba Combo PN test for simultaneous detection of ESBL and carbapenemase activity in Enterobacterales
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.01123-26 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Soraya Herrera-Espejo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Enterobacteriaceae. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Reference Center for Emerging Antibiotic Resistance (NARA), Fribourg, Switzerland, Université de Fribourg.
Abstract (Originalsprache)
A chromogenic biochemical assay (ESBL-Carba Combo PN test) was developed for the simultaneous detection of extended-spectrum β-lactamase (ESBL) and carbapenemase activity in Enterobacterales, as well as for discrimination of clinically relevant carbapenemase classes. The assay is based on a novel chromogenic substrate, B-Lac, and a low-cost Tris-based lysis buffer, providing a unified workflow for the detection of ESBLs and carbapenemases. The test was evaluated using cultures of well-characterized clinical isolates with resistance mechanisms previously defined by whole-genome sequencing. Results were obtained after a mean preparation time of approximately 3 min per isolate and were read after 20 min and 1 h of incubation. For ESBL detection ( n = 67), sensitivity was 93.8% and 97.8% after 20 min and 1 h of incubation, respectively, with a specificity of 100%. Carbapenemase activity ( n = 92) was detected with 100% sensitivity and specificity at both time points. Using the combined assay ( n = 85), ESBL and/or carbapenemase activity was detected with 100% sensitivity and specificity. For Ambler classes A and B, 100% sensitivity and specificity were reached after 20 min of incubation. Regarding class D carbapenemases, 91.3% and 95.5% sensitivity after 20 min and 1 h of incubation, respectively, were observed, with 100% specificity at both times. The ESBL-Carba Combo PN test provides a simple, low-cost (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
- D-Tek SA, Mons, Belgium.
- Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
ORCID-Profile: Soraya Herrera-Espejo, Jacqueline Findlay, Patrice Nordmann
Förderung
- National Reference Center for Emerging Antibiotic Resistance (NARA), Fribourg, Switzerland
- Université de Fribourg
Zitieren
APA
Herrera-Espejo, S., Findlay, J., Bouvier, M., Viguier, C., Klahre, M., Bodart, N., & Nordmann, P. (2026). Rapid ESBL-Carba Combo PN test for simultaneous detection of ESBL and carbapenemase activity in Enterobacterales. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01123-26
Vancouver
Herrera-Espejo S, Findlay J, Bouvier M, Viguier C, Klahre M, Bodart N, et al. Rapid ESBL-Carba Combo PN test for simultaneous detection of ESBL and carbapenemase activity in Enterobacterales. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01123-26
BibTeX
@article{HerreraEspejo2026,
author = {Herrera-Espejo, Soraya and Findlay, Jacqueline and Bouvier, Maxime and Viguier, Clément and Klahre, Maurice and Bodart, Nicolas and Nordmann, Patrice},
title = {Rapid ESBL-Carba Combo PN test for simultaneous detection of ESBL and carbapenemase activity in Enterobacterales},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.01123-26}
}
EUVIMED